Safe treatment of head/neck AD with tacrolimus ointment

Sewon Kang, A. Paller, N. Soter, Y. Satoi, M. J. Rico, J. M. Hanifin

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

BACKCROUND: Atopic dermatitis (AD) with head and neck involvement is common and therapeutically challenging. METHODS: Efficacy and safety data specific to treatment of head/neck regions with tacrolimus ointment (Protopic®) from three double-blind, randomized, vehicle-controlled studies are reported. A total of 631 adult and 352 pediatric patients with moderate to severe atopic dermatitis applied the vehicle, 0.03% or 0.1% tacrolimus ointment twice daily to affected areas for up to 12 weeks. RESULTS: Significant improvements from baseline to end of treatment for signs of atopic dermatitis (erythema, edema, excoriation, oozing, scaling, and lichenification) were noted for head/neck and non-head/neck areas treated with either 0.03% or 0.1% tacrolimus ointment (p<0.001). Within each treatment group, the overall 12-week adjusted incidence rate of application site adverse events was similar for both head/neck and non-head/neck areas. The incidence of common adverse events such as pruritus, "skin burning", erythema, infection, and skin tingling in head/neck areas was comparable to that observed in non-head/neck areas within each treatment group. The overall prevalence of application site adverse events decreased rapidly during the first few days of treatment. CONCLUSION: Tacrolimus ointment is a safe and effective treatment for atopic dermatitis on the head and neck.

Original languageEnglish (US)
Pages (from-to)86-94
Number of pages9
JournalJournal of Dermatological Treatment
Volume14
Issue number2
DOIs
StatePublished - Jun 2003

    Fingerprint

Keywords

  • Atopic dermatitis
  • Head/neck
  • Tacrolimus ointment

ASJC Scopus subject areas

  • Dermatology

Cite this